Sydney scientists develop world-first drug to fight incurable children’s cancer | 7NEWS

7NEWS Australia published this video item, entitled “Sydney scientists develop world-first drug to fight incurable children’s cancer | 7NEWS” – below is their description.

Sydney scientists have made a world first breakthrough in the fight against an incurable children’s cancer, called diffuse intrinsic pontine glioma, that claims the lives of its young sufferers in a matter of months. Their research now sparking a global clinical trial hoped to be the first step towards a cure.

7NEWS Australia YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - 7NEWS Australia

Seven News is the television news service of the Seven Network and, as of 2016, the highest-rating in Australia. The news service draws upon overseas channels for select international coverage. The network’s Director of News and Current Affairs is Craig McPherson.

Recent from 7NEWS Australia:

  • Rise in compensation claims from catching COVID at work | 7NEWS
  • New claims that Queensland won’t open its borders until 90 per cent double vaccination | 7NEWS
  • Pfizer vaccine deemed safe for children aged 5 to 11 | 7NEWS
  • In This Story: Sydney

    Sydney, capital of New South Wales and one of Australia‘s largest cities, is best known for its harbourfront Sydney Opera House, with a distinctive sail-like design.

    • Population: 5.23 million (2018)

    3 Recent Items: Sydney

  • Growing number of Sydney households struggle to pay down their loans | ABC News
  • Mortgage stress on the rise in Sydney as property prices climb | 7NEWS
  • Yagoona CCTV released by police involved in Sydney murder investigations | 7NEWS
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.